SUBJECTIVE EXPERIENCE MEASUREMENT IN PATIENTS WITH SCHIZOPHRENIA/SCHIZOAFFECTIVE DISORDER USING THE NOVEL ANTIPSYCHOTIC MEDICATION EXPERIENCE SCALE (NAMES)

被引：0
|
作者：
Wirshing, Donna A. [1 ]
Rosen, J. [1 ]
Pierre, J. M. [1 ]
Erickson, Z. D. [1 ]
Guzik, L. H. [1 ]
Mena, S. J. [1 ]
机构：
[1] VA Greater Angeles Healthcare Syst, Los Angeles, CA USA
来源：
SCHIZOPHRENIA BULLETIN | 2009年 / 35卷
关键词：
D O I：
暂无
中图分类号：
R749 [精神病学];
学科分类号：
100205 ;
摘要：
引用
收藏
页码：36 / 36
页数：1
相关论文
共 50 条
  • [21] The Brief Adherence Rating Scale (BARS) validated against electronic monitoring in assessing the antipsychotic medication adherence of outpatients with schizophrenia and schizoaffective disorder
    Byerly, Matthew J.
    Nakonezny, Paul A.
    Rush, A. John
    SCHIZOPHRENIA RESEARCH, 2008, 100 (1-3) : 60 - 69
  • [22] DECREASED HAND BLOOD FLOW CORRELATES WITH SYMPTOM SEVERITY AND IS ACUTELY INCREASED BY ATYPICAL ANTIPSYCHOTIC MEDICATION IN PATIENTS WITH SCHIZOPHRENIA AND SCHIZOAFFECTIVE DISORDER
    Blessing, Esther
    Kader, Linda
    Ootsuka, Youichirou
    Blessing, William W.
    Pantelis, Christos
    SCHIZOPHRENIA RESEARCH, 2012, 136 : S136 - S136
  • [23] The Glasgow antipsychotic side-effects scale for clozapine in inpatients and outpatients with schizophrenia or schizoaffective disorder
    Ristic, Dragana Ignjatovic
    Cohen, Dan
    Obradovic, Andrea
    Nikic-Duricic, Katarina
    Draskovic, Marija
    Hinic, Darko
    NORDIC JOURNAL OF PSYCHIATRY, 2018, 72 (02) : 124 - 129
  • [24] Predictors of medication discontinuation by patients with first-episode schizophrenia and schizoaffective disorder
    Robinson, DG
    Woerner, MG
    Alvir, JMJ
    Bilder, RM
    Hinrichsen, GA
    Lieberman, JA
    SCHIZOPHRENIA RESEARCH, 2002, 57 (2-3) : 209 - 219
  • [25] Cognitive effects of antipsychotic dosage and polypharmacy: a study with the BACS in patients with schizophrenia and schizoaffective disorder
    Elie, D.
    Poirier, M.
    Chianetta, J. M.
    Durand, M.
    Gregoire, C. A.
    Grignon, S.
    JOURNAL OF PSYCHOPHARMACOLOGY, 2010, 24 (07) : 1037 - 1044
  • [26] Sexual function and gonadal hormones in patients taking antipsychotic treatment for schizophrenia or schizoaffective disorder
    Howes, Oliver D.
    Wheeler, Michael J.
    Pilowsky, Lyn S.
    Landau, Sabine
    Murray, Robin M.
    Smith, Shubulade
    JOURNAL OF CLINICAL PSYCHIATRY, 2007, 68 (03) : 361 - 367
  • [27] Evaluation of subjective experience of cognitive deficit in patients with schizophrenia using the Eppendorf Schizophrenia Inventory
    Mass, R.
    Agadzhanov, V.
    ZHURNAL NEVROLOGII I PSIKHIATRII IMENI S S KORSAKOVA, 2006, 106 (07): : 41 - 45
  • [28] The interaction of subjective experience and attitudes towards specific antipsychotic-related adverse effects in schizophrenia patients
    Fischel, T.
    Krivoy, A.
    Kotlarov, M.
    Zemishlany, Z.
    Loebstein, O.
    Jacoby, H.
    Weizman, A.
    EUROPEAN PSYCHIATRY, 2013, 28 (06) : 340 - 343
  • [29] Antipsychotic Medication Doses in Schizophrenia and Schizoaffective Disorder Patients with Cannabis Positive Urine Test vs. Those with Negative Urine Test
    Elkhatib, Rania
    Satyajit, Mohite
    Ngana, Ikenna
    Burns, Wilma
    Okusaga, Olaoluwa
    BIOLOGICAL PSYCHIATRY, 2014, 75 (09) : 265S - 265S
  • [30] Clinical Determinants, Patterns, and Outcomes of Antipsychotic Medication Prescribing in the Treatment of Schizophrenia and Schizoaffective Disorder: A Naturalistic Cohort Study
    Groenendaal, Emily
    Lynch, Sean
    Dornbush, Rhea
    Klepacz, Lidia
    Ferrando, Stephen
    CNS SPECTRUMS, 2023, 28 (02) : 226 - 227
12345